News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MacDougall Ann L.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/03/2023 |
4
| MacDougall Ann L. (Director) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 26,179 shares
@ $20, valued at
$523.6k
Disposed/sold 2,000 shares
@ $20, valued at
$40k
Disposed/sold 2,500 options to buy
@ $15.56, valued at
$38.9k
Disposed/sold 2,500 options to buy
@ $12.75, valued at
$31.9k
Disposed/sold 2,500 options to buy
@ $8.79, valued at
$22k
Disposed/sold 2,500 options to buy
@ $13.3, valued at
$33.3k
|
|
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| MacDougall Ann L. (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC|
Txns:
| Disposed/sold 40,000 options to buy
@ $5.01, valued at
$200.4k
Disposed/sold 36,065 options to buy
@ $5.01, valued at
$180.7k
|
|
| 06/15/2020 |
4
| MacDougall Ann L. (Director) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 2,000 shares
@ $0
Granted 2,500 options to buy
@ $8.79, valued at
$22k
|
|
| 12/17/2019 |
4
| MacDougall Ann L. (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC|
Txns:
| Granted 36,065 options to buy
@ $5.01, valued at
$180.7k
|
|
| 12/17/2019 |
4
| MacDougall Ann L. (Director) has filed a Form 4 on PROGENICS PHARMACEUTICALS INC|
Txns:
| Granted 40,000 options to buy
@ $5.01, valued at
$200.4k
|
|
| 12/12/2019 |
4
| MacDougall Ann L. (Director) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Bought 5,000 shares
@ $14.54, valued at
$72.7k
|
|
| 09/27/2019 |
3
| MacDougall Ann L. (10% Owner) has filed a Form 3 on PROGENICS PHARMACEUTICALS INC |
| 06/13/2019 |
4
| MacDougall Ann L. (Director) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 2,500 options to buy
@ $12.75, valued at
$31.9k
|
|
| 06/14/2018 |
4
| MacDougall Ann L. (Director) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 2,500 options to buy
@ $15.56, valued at
$38.9k
|
|
| 06/05/2018 |
4
| MacDougall Ann L. (Director) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Bought 106 shares
@ $16.5, valued at
$1.7k
Bought 611 shares
@ $16.75, valued at
$10.2k
Bought 100 shares
@ $16.83, valued at
$1.7k
Bought 50 shares
@ $16.28, valued at
$814
Bought 50 shares
@ $16, valued at
$800
Bought 200 shares
@ $16.25, valued at
$3.3k
Bought 195 shares
@ $16.95, valued at
$3.3k
Bought 286 shares
@ $16.97, valued at
$4.9k
Bought 100 shares
@ $15.98, valued at
$1.6k
Bought 100 shares
@ $16.29, valued at
$1.6k
Bought 200 shares
@ $16.3, valued at
$3.3k
|
|
| 08/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/27/2016 |
3
| MacDougall Ann L. (Director) has filed a Form 3 on OPIANT PHARMACEUTICALS, INC. |
|
|